Uncovering Institutional Buying In G1 Therapeutics Inc (NASDAQ: GTHX)
Currently, there are 51.93M common shares owned by the public and among those 43.18M shares have been available to trade. The company’s stock has a 5-day price change of 0.42% and 109.71% over the past three months. GTHX shares are trading 133.77% year to date (YTD), with the 12-month market performance up to 324.40% higher. […]
G1 Therapeutics Inc (GTHX) Testing Investors’ Patience Right Now
Currently, there are 51.93M common shares owned by the public and among those 42.79M shares have been available to trade. The company’s stock has a 5-day price change of 0.28% and 56.04% over the past three months. GTHX shares are trading 132.79% year to date (YTD), with the 12-month market performance up to 290.11% higher. […]
Is G1 Therapeutics Inc (NASDAQ: GTHX) Proving The Doubters Wrong?
G1 Therapeutics Inc (GTHX) concluded trading on Wednesday at a closing price of $7.06, with 34.81 million shares of worth about $245.73 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 50.21% during that period and on August 07, 2024 the price saw a […]
Handle With Care: G1 Therapeutics Inc (NASDAQ: GTHX)
Currently, there are 51.93M common shares owned by the public and among those 43.56M shares have been available to trade. The company’s stock has a 5-day price change of -20.14% and -44.50% over the past three months. GTHX shares are trading -27.21% year to date (YTD), with the 12-month market performance down to -14.94% lower. […]
G1 Therapeutics Inc (NASDAQ: GTHX): Hunting Genuine Value In Market Debris
Currently, there are 51.50M common shares owned by the public and among those 42.75M shares have been available to trade. Insiders at the company have transacted a total of 22 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, […]
G1 Therapeutics Inc (NASDAQ: GTHX) Is Getting Increasingly Hard To Ignore
Millennium Management LLC recently announced the acquisition of new stake in G1 Therapeutics Inc (NASDAQ:GTHX). The institutional investor has increased its shareholding in the Healthcare company by 72.51% to 1.05 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 2.03% valued currently at $1.73 million. In addition, Raymond […]
Growth Story Still Intact For G1 Therapeutics Inc (GTHX)
Millennium Management LLC has recently announced that it has increased stake in G1 Therapeutics Inc (NASDAQ:GTHX) by 72.51%. After grabbing 1.05 million shares, the institutional investor is now in possession of 0.44 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.03% having worth around $1.73 million. Moreover, […]
